MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Short-term marketablesecurities$513,679K Cash and cashequivalents$157,522K Prepaid expenses andother current assets$18,346K Contract assets$6,560K Total property andequipment$23,579K Total current assets$696,107K Long-term marketablesecurities$301,713K Right-of-use assets$22,613K Property and equipment,net$8,634K Restricted cash$1,281K Less accumulateddepreciation and...$14,945K Total assets$1,030,348K Total liabilities andstockholders equity$1,030,348K Total stockholdersequity$937,267K Total liabilities$93,081K Accumulated deficit-$835,078K Accumulated othercomprehensive (loss) income-$494K Additional paid-in capital$1,772,830K Total currentliabilities$64,831K Long-term operating leaseliabilities$28,250K Common stock, 0.0001par value,...$9K Accrued liabilities$43,745K Accounts payable$20,736K Operating leaseliabilities, current$350K
Balance Sheet

IDEAYA Biosciences, Inc. (IDYA)

IDEAYA Biosciences, Inc. (IDYA)

source: myfinsight.com